CAPTRUST Financial Advisors
IART icon

CAPTRUST Financial Advisors’s Integra LifeSciences IART Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-23,369
Closed -$681K – 2325
2024
Q2 		$681K Buy
23,369
+5,455
+30% +$162K ﹤0.01% 1360
2024
Q1 		$635K Buy
17,914
+3,704
+26% +$148K ﹤0.01% 1366
2023
Q4 		$619K Buy
14,210
+1,871
+15% +$73.6K ﹤0.01% 1585
2023
Q3 		$471K Sell
12,339
-1,698
-12% -$71.4K ﹤0.01% 1682
2023
Q2 		$577K Buy
14,037
+3,264
+30% +$157K ﹤0.01% 1546
2023
Q1 		$618K Sell
10,773
-112
-1% -$6.31K ﹤0.01% 1291
2022
Q4 		$610K Buy
10,885
+6,041
+125% +$307K ﹤0.01% 1239
2022
Q3 		$205K Sell
4,844
-8
-0.2% -$410 ﹤0.01% 1809
2022
Q2 		$262K Buy
4,852
+2,849
+142% +$171K ﹤0.01% 1504
2022
Q1 		$129K Buy
2,003
+976
+95% +$64.3K ﹤0.01% 2076
2021
Q4 		$69K Sell
1,027
-3,107
-75% -$210K ﹤0.01% 2423
2021
Q3 		$283K Buy
4,134
+265
+7% +$18.7K ﹤0.01% 1330
2021
Q2 		$264K Sell
3,869
-59
-2% -$4.17K ﹤0.01% 1344
2021
Q1 		$271K Buy
3,928
+428
+12% +$29K ﹤0.01% 1287
2020
Q4 		$227K Sell
3,500
-39
-1% -$2.1K ﹤0.01% 1139
2020
Q3 		$167K Buy
3,539
+1,151
+48% +$54.8K ﹤0.01% 1117
2020
Q2 		$116K Hold
2,388
– – ﹤0.01% 1282
2020
Q1 		$102K Buy
+2,388
New +$125K ﹤0.01% 1116
2019
Q4 		– Sell
-2,045
Closed -$123K – 1364
2019
Q3 		$123K Sell
2,045
-115
-5% -$6.85K ﹤0.01% 702
2019
Q2 		$121K Buy
2,160
+3
+0.1% +$154 ﹤0.01% 692
2019
Q1 		$120K Sell
2,157
-173
-7% -$8.81K ﹤0.01% 640
2018
Q4 		$105K Buy
2,330
+707
+44% +$38.8K 0.01% 572
2018
Q3 		$107K Buy
1,623
+13
+0.8% +$808 ﹤0.01% 572
2018
Q2 		$104K Buy
1,610
+199
+14% +$12.3K 0.01% 500
2018
Q1 		$76K Sell
1,411
-468
-25% -$24.5K ﹤0.01% 504
2017
Q4 		$90K Buy
+1,879
New +$92K 0.01% 464

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CAPTRUST Financial Advisors's IART Position: Q3 2024 in Review

CAPTRUST Financial Advisors sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 23,369 shares — an estimated $681K sold.

CAPTRUST Financial Advisors first reported a position in IART in Q4 2017 and held it in 26 quarters. The position peaked at $681K in Q2 2024. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • CAPTRUST Financial Advisors reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 23,369 Integra LifeSciences shares in Q3 2024, an estimated $681K.
  • CAPTRUST Financial Advisors first reported a position in Integra LifeSciences in Q4 2017 and held it in 26 quarters.
  • CAPTRUST Financial Advisors's Integra LifeSciences position peaked at $681K in Q2 2024.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.